Eurofins-Cerep

Historical price data

Eurofins-Cerep operates as a high-value service unit within Eurofins Scientific, executing mission-critical drug discovery and safety testing for external clients. Its core achievement is the integration of its deep, specialized pharmacology expertise with Eurofins' vast global laboratory network, creating a powerful 'one-stop-shop' for early-stage R&D. The company's strategy is to leverage this unique position to capture a larger share of the growing outsourced R&D market, particularly in complex, integrated study designs. Its success is measured by its ability to accelerate and de-risk its clients' pipelines, thereby securing recurring and project-based revenue.

A comprehensive panel of over 800 validated in vitro assays for integrated pharmacology, ADME-Tox, and safety profiling, supported by custom study design and data integration capabilities.

Eurofins-Cerep competes with large, full-service CROs (e.g., Charles River Labs) on specialization and with focused discovery CROs (e.g., Evotec) on scale and network integration. Its unique position as a deep specialist within a vast testing network is its primary competitive moat.